ORGO · Organogenesis Holdings Inc
United States · RS rating 4 · As of 2026-11-03
| Price | 0.83 USD |
|---|---|
| 1-day change | +10.4% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 9 / 5 / 9 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 6 / 36 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +118.2% |
| Sales growth Q/Q | +49.6% |
| Distance from 52-week high | +87.2% |
| Market cap (USD) | $299.7M |